Superoxide anion and other oxygen-free radicals have been implimade with preterm animal and human lungs suggest that cated in the pathogenesis of bronchopulmonary dysplasia. We premature lungs might be deficient in antioxidant enzymes tested the hypothesis that a catalytic antioxidant metalloporphyrin (8)(9) (10) . In addition, inflammatory mediators that are sensitive have been shown to catalyze the release of O 2 from hydrogen peroxide, scavenge peroxynitrite, and inhibit lipid peroxida-
tion (15) .
neuroendocrine cells
Manganese-containing porphyrins have been shown to protect cells against a variety of oxidative stress-inducing The pathogenesis of bronchopulmonary dysplasia (BPD) is agents in vitro, including heat shock, xanthine/xanthine oxithought to be multifactorial, with prematurity, barotrauma, dase, paraquat, and lipopolysaccharide (15) . Metalloporphyinflammation, and pulmonary O 2 toxicity playing important rins have also been shown to provide protection in vivo against roles (1). Evidence suggests that an oxidant/antioxidant imparaquat-induced lung injury (16, 17) , endotoxin shock (18) , balance exists in lungs that are at risk for BPD. Higher conand cardiomyopathy in manganese SOD knockout mice (19) . centrations of lipid peroxidation metabolites such as F 2 -isoPreterm fetal baboons delivered by caesarean section at prostanes have been found in premature infants (2, 3). Infants 140 days of gestation (term ϭ 185 days) and maintained on who develop BPD have elevated endothelin-1 in tracheal 100% O 2 for 10 days develop clinical and pathologic features aspirates (4), known to prime both neutrophils and macrothat resemble severe BPD (20, 21) . We report here that phages to produce more superoxide (5). Preterm babies have the administration of the catalytic antioxidant AEOL 10113 lower levels of retinoic acid (6), which has been shown to (Incara Pharmaceuticals Corporation, Research Triangle suppress both superoxide and hydrogen peroxide formation Park, NC) to premature baboons inhibits alveolar structural in stimulated neutrophils and macrophages (7). Observations modifications and inflammation induced by 100% oxygen; reduces urine levels of bombesin-like peptide (BLP), a proinflammatory peptide and bronchoconstrictor; and reduces the numbers of pulmonary neuroendocrine cells, mast cells, and (Received in original form March 20, 2002 ; accepted in final form September 5, 2002) eosinophils.
baboon as previously described (22) . Animals were given either 100% O 2 continuously or oxygen pro re nata (PRN O 2 ). Because AEOL 10113 has a serum half-life of 0.5 to 1 hour in mice, the antioxidant was administered to 100% O 2 -exposed baboons by continuous intravenous infusion at a dose of 0.5 mg/kg/day using an infusion rate of 0.1 cc/ hour. A preliminary 2-week toxicity study in mice using continuous infusion of the drug (by miniosmotic pumps) was performed. No toxic effect was found by pathology (liver and kidney) and serum levels of alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase, total bilirubin, urea nitrogen, and creatinine at 5 mg/kg/day. Because of the immature and precious nature of the neonatal baboons used in this study, a dose 10-fold lower was chosen. Baboons were supported in a neonatal intensive care unit for 10 days. Details on sample collection are given in the online supplement.
Pharmacokinetics
The concentrations of AEOL 10113 in serum and necropsy tissue sam- Figure 1 . Chemical structure and properties of AEOL 10113. IC 50 ϭ the ples were analyzed by Analytical Solutions, Inc. (Raleigh, NC) using concentration required for 50% inhibition. a Ranin high-performance liquid chromatography system. Details of the analytical method are provided in the online supplement.
Morphometry and Pathology
the 10th day (Figure 2 ). AEOL 10113 levels in lung, liver, and Pathologic and morphometric studies were performed on hematoxylin and eosin-stained paraffin sections of the right lower lobes fixed by kidney at autopsy were 331 Ϯ 92 ng/g, 7,229 Ϯ 1,724 ng/g, and bronchial instillation with 2% glutaraldehyde. Point and intercept 2,441 Ϯ 533 ng/g, respectively. The heart contained approxicounting were performed to determine the absolute volume and the mately 60 ng of AEOL 10113 per gram of tissue. Traces of the surface area of alveolar tissue as well as the thickness of the alveolar drug were detected in the brain (frontal cortex) of only one of septum using methods previously described (23) . Estimation of the the seven AEOL 10113-treated animals, suggesting that the fractional volume of the parenchyma involved in severe atelectasis, blood/brain barrier remained intact for the most part during the fibrosis, or overinflation was made. "Inflammation index," an indicator hyperoxic exposure. Examination of hematoxylin and eosinfor the severity of inflammation, was derived using a semiquantitative stained and Pentachrome-stained sections of liver and kidney scoring system. The numbers of neuroendocrine cells, eosinophils, mast revealed no detectable tissue injuries. cells, and neutrophils per square millimeter of parenchymal tissue were measured as described previously (24, 25) . Additional details on the Antioxidant Enzymes methods for making these measurements are provided in the online supplement.
Total lung protein for the three groups of baboons were 50 Ϯ 6.4, 53.2 Ϯ 5.2, and 51.6 Ϯ 3.2 mg/g lung for PRN, 100% O 2 , and
Western Blots
100% O 2 ϩ AEOL 10113 groups, respectively. Neither hyperoxia Lung protein expressions of the inducible nitric oxide synthase, manganor AEOL 10113 appeared to affect the overall protein synthesis nese SOD, and extracellular SOD were analyzed using standard Westin the lung. Protein expressions of manganese SOD and extracelern blot procedures (26) . lular SOD were measured to see whether the regulation of these antioxidant enzymes was affected in hyperoxia-stressed lungs by Urine BLP treatment with a catalytic antioxidant. Analysis of the immuUrine was collected from the newborn baboons as 24-hour pooled noblots for the two antioxidant enzymes revealed that exposure samples (5-50 ml total volume) and stored at Ϫ70ЊC. BLP levels were to 100% O 2 for 10 days did not significantly affect the protein measured by radioimmunoassay as described by Sunday and colleagues expression of manganese SOD but inhibited the expression of (27) . from the three groups for all the variables except oxygenation indices (OIs). A mixed-effects model was used to compare OIs between the three groups. For this repeated-measurement data, pairwise comparisons for contrasting between-group OIs at different time points were made via analysis of variance. To observe time effect, orthogonal polynomials are applied. A two-tailed p value of 0.05 was considered statistically significant for all comparisons. Statistical analyses were performed using the SAS System (SAS Institute, Inc., Cary, NC). slightly after the 6th day to 320 ng/ml and reached 390 ng/ml by 
RESULTS

Pharmacokinetics
Histology Evaluation
Pathologic changes similar to those previously described for this baboon model of BPD were observed. The characteristic Physiology overinflated airspaces (22) associated with BPD were observed in animals exposed to 100% O 2 , and to a lesser extent, in the There was no difference in the birth weights of the animals in PRN O 2 and AEOL 10113-treated animals. Areas of massive the three experimental groups (PRN O 2 , 534 Ϯ 18 g; 100% O 2 , atelectasis, pulmonary interstitial emphysema, and honeycomb 527 Ϯ 14 g; 100% O 2 ϩ AEOL 10113, 567 Ϯ 20 g). The clinical lung associated with severe interstitial fibrosis were prominent course of the animals in either the PRN O 2 , the 100% O 2 , or in the 100% O 2 -exposed animals without antioxidant treatment. the 100% O 2 ϩ AEOL 10113 groups was similar. Table 1 lists Figures 5A-5C show representative low magnification views of the key ventilation and blood-gas parameters. To compare the baboon lungs from the three groups of animals. Extensive alveostatus of oxygenation in the three groups of animals, the OI, lar wall thickening was found most frequently in the 100% O 2 -defined by the formula here, was calculated: OI ϭ fraction of ventilated animals. Trichrome stain revealed collagen deposition inspired oxygen ϫ mean airway pressure ϫ 100 Ϭ PO 2 . A normal mostly in peribronchiolar and perivascular spaces. Diffuse stain-OI is low, in the range of one to two. Data from 20 PRN O 2 ing was also seen in the interstitium of thickened alveolar septa animals as well as 21 100% O 2 -exposed animals were pooled ( Figure 5E ); 100% O 2 ϩ AEOL 10113-treated animals, in genfor comparison with the 7 100% O 2 ϩ AEOL 10113-treated eral, displayed less collagen staining than nontreated 100% O 2 fetal baboons. Typically, the OI of animals in all groups started control subjects ( Figure 5F ). In the bronchi of 100% O 2 -above 10 immediately after delivery and then decreased to below ventilated baboons, changes included epithelial hyperplasia, 8 by 8 to 12 hours after delivery. There was no difference in OI squamous metaplasia, and mucous plugging of small airways during the first 12 hours of life between the three groups of (20) . The incidents of mucous plugging were reduced in AEOL animals. Figure 4 compares the OIs of the three groups of animals 10113-treated animals compared with those with 100% O 2 alone. for Days 6 to 10. The 100% O 2 group showed a significant positive trend (p Ͻ 0.0001) of increasing OI over time. The trend was
Morphometry
Marked changes were found in the alveolar region of the baboon lungs exposed to 100% O 2 (Table 2 ). Exposure to 100% O 2 significantly increased the total volume of alveolar tissue when group. In addition, the mean alveolar surface area was greater than that found in the 100% O 2 animals.
Definition of abbreviations: FI O 2 ϭ fraction of inspired oxygen; MAWP ϭ mean
The mean volumes of the right lower lobes of the three groups airway pressure; PEEP ϭ peak end-expiratory pressure; PIP ϭ peak inspiratory pressure; PRN ϭ pro re nata.
of animals were similar (Table 2) . Total tissue volume of the airway and vessel compartments, the surface area of the conductmillimeter of lung parenchyma were not affected by treatment with AEOL 10113. Counting of eosinophils and mast cells on ing airways and the blood vessels, and the thickness of the airway or vessel walls were also similar among the three groups of fetal lung sections showed increases of both types of inflammatory cells in the parenchyma of 100% O 2 animals. AEOL 10113 treatbaboons studied (data not shown).
Reduced alveolar injury in 100% O 2 ϩ AEOL 10113-treated ment reduced the cell counts to the level observed in PRN O 2 animals ( Figure 7 ). We found no statistical significance of lung fetal baboons in relationship to animals exposed to 100% O 2 was also indicated by a significant reduction in the proportion inducible nitric oxide synthase protein expressions among 140-day gestation fetal baboons, 140-day gestation plus 10-day of the right lower lung involved in overinflation, fibrosis, or severe atelectasis ( Figure 6A ). Although 40% of the right lower PRN-exposed baboons, 140-day gestation plus 10-day 100% O 2 -exposed fetal baboons, or AEOL 10113-treated fetal baboons. lobes from 100% O 2 animals were found to display collapsed alveolar septa or fibrosis, only 14% of the right lower lobes Neuroendocrine Cells and BLP from 100% O 2 ϩ AEOL 10113-treated animals showed this pathology.
Hyperplasia of the neuroendocrine cells was observed in the small airways and parenchyma of fetal baboon lungs exposed significant rise in BLP levels at Day 2 after birth (mean twofold in hematoxylin and eosin or Pentachrome sections after 10 days of treatment at the current dose. The effect of chronic dosing increase) has been shown to be associated with the development in fetal baboons remains to be determined. of BPD in baboons. We also expressed urine BLP levels in the Ten days of 100% O 2 exposure of these neonatal animals led Day 2 samples as the percentage change from the normalized to structural remodeling, primarily in the alveolar region of the mean urine BLP values in samples collected during Day 1 (Figlung . The total thickness of the walls of either large or mediumures 8C and 8D). The sharp percentage increase in urine BLP sized vessels or airways was not changed by hyperoxia. Because levels seen in 100% O 2 -exposed animals was inhibited by the of considerable variation in the magnitude of alveolar pathology AEOL 10113 treatment.
among the individual fetal baboons in the PRN O 2 group in this study, there was no significant difference between the means of DISCUSSION alveolar septal thickness and total alveolar surface area of the In this study, a manganese-containing porphyrin with high SOD PRN O 2 and 100% O 2 groups. However, the volume of total activity was used to test the benefit of antioxidant treatment in alveolar tissue was significantly greater in the 100% O 2 group. a baboon model of BPD with exposure to 100% O 2 . It should AEOL 10113-treated animals demonstrated thinner septa and be noted that this model of BPD resembles the BPD described greater alveolar surface area than animals exposed to 100% O 2 by Northway and colleagues where inflammation, fibrosis, and without the antioxidant. The protective effect of the catalytic smooth muscle hypertrophy in the airways resulted from meantioxidant may have resulted from improved recruitment of chanical injury and oxygen exposure (29). With advances in alveoli, since the fraction of alveolar tissue involved in severe neonatal care, including the use of antenatal steroid and surfacatelectasis and overinflation was reduced in drug-treated fetal tant and reduced use of high-oxygen tensions, BPD occurs today baboon lungs. It is also possible that AEOL 10113 may protect primarily in severely underweight infants with abnormal lung against hyperoxia-induced inhibition of alveolarization. In addidevelopment as the main consequence (30) .
tion, the amount of fibrosis in the alveolar interstitium of 100% The dose of AEOL 10113 given to the fetal baboons was O 2 ϩ AEOL 10113-treated fetal baboon lungs also appeared to low, being 1/10 of the dose with which no toxicity was observed be decreased. in mice. Pharmacokinetic analysis of the serum samples from
The severity of inflammation was also reduced in the airway AEOL 10113-treated fetal baboons showed that the serum conlumen, alveolar airspaces, and parenchyma. The ability of AEOL centration of the drug quickly equilibrated during the first day 10113 to inhibit inflammatory cell recruitment appeared to be and remained stable during Days 2 through 5. The increase of most pronounced for mast cells and eosinophils but not neutro-AEOL 10113 in serum during the second half of the oxygen phils. Taken together, these analyses suggest that the AEOL exposure and high concentrations of the drug in both the kidney 10113 treatment inhibits specific inflammatory cell responses in and the liver at necropsy suggest a slowing down of its removal this baboon model of BPD. Decreased recruitment of inflammafrom the circulation by excretion and/or metabolism. Although tory cells could possibly reduce alveolar damage by oxygen free accumulation of the drug may indicate impairment of liver and/ radicals or other toxic leukocyte products, such as mast cell tryptase and eosinophil cationic protein (31, 32) . The mechanism or kidney function, no overt liver or kidney injury was observed for the inhibition of leukocyte recruitment by AEOL 10113 treated baboons. Nevertheless, our results suggest stabilization of the OI in drug-treated animals. is unknown. We speculate that AEOL 10113 may inhibit the activation of the transcription factor nuclear factor-B and the This study shows that AEOL 10113 inhibited 100% O 2 --induced alveolar structural remodeling, demonstrating a therasubsequent induction of chemokines and cytokines involved in the inflammatory cascade. We have recently demonstrated that peutic effect of the antioxidant against oxygen toxicity. The benefit of the antioxidant treatment for present day BPD where treatment with AEOL 10113 inhibited ovalbumin-induced vascular adhesion molecule-1 expression in mice (33) . AEOL 10113 lower oxygen tensions are used and the primary pathology is one of arrested lung development is less certain (30) . However, is capable of scavenging a wide range of oxidants, including superoxide, hydrogen peroxide, and peroxynitrite (15) . These hyperoxia has been shown to inhibit lung growth (44, 45). Alveolar development in SOD knockout mice was observed in mice activities might protect against tissue injuries caused by toxic oxygen metabolites generated by inflammatory cells, including kept in room air and 50% O 2 (46). Recent findings of increased oxidative stress (2-7) and low levels of antioxidants in fetal lungs neutrophils. AEOL 10113 has been shown to reduce oxidative stress-induced inactivation of aconitase and 8-hydroxy-2Ј-deoxy- (47, 48) suggest that redox balance could play a role in the arrest of lung growth in BPD, and that antioxidant augmentation could guanosine formation in a rat model of ischemic brain injury (34) . We believe that decreased inflammatory response in antioxidantalso be of benefit in this situation. Concern has been raised in recent years about the safety of antioxidant treatment for BPD treated animals as well as possible antioxidant protection against lung injury from inflammatory cells may contribute to reduced due to inhibition of cell growth by some antioxidants (49) . AEOL 10113 is being tested in a 125-day gestation baboon model of fibrosis, hyperplasia, and tissue consolidation.
Exposure of fetal baboons to 100% O 2 caused a decrease in BPD maintained with PRN O 2 for 14 days. Preliminary results on this model of BPD have been reported to show that treatment the lung expression of extracellular SOD. The loss of this enzyme could be an important contributor to lung injury. Although treatwith the antioxidant enhanced the development of secondary septa in PRN O 2 -treated animals, suggesting that AEOL 10113 ment with AEOL 10113 did not alter the downregulation of extracellular SOD, we speculate that AEOL 10113 might partidoes not inhibit lung growth (50) . BPD is a chronic lung disease of the premature infant. Adolescents and young adults who tion in tissue in a manner similar to extracellular SOD because it carries a charge of five (28). AEOL 10113 could protect against suffered from BPD in infancy have persistent abnormalities in pulmonary function (51) consistent with irreversible structural alveolar injury by effectively replacing the lost extracellular SOD in the extracellular milieu, where the presence of antioxidants changes. Morphometric studies of the lungs of young children who died with BPD showed severe alveolar structural changes to protect against inflammatory cells is important (35) .
BLP is a family of neuropeptides associated with morphogenwith decreased alveolar internal surface area (52). Structural alterations in the lungs resulting from BPD can be an important esis, growth, and maturation (36, 37) . Gastrin-releasing peptide is the major known BLP associated with lung development in factor for long-term consequences. Preventing permanent structural changes from occurring is likely to result in the improvemice, rats, and humans (38) . Pulmonary neuroendocrine cells stained positive for BLP have been shown to increase after ment of lung functions in later life. We conclude that antioxidant treatment with low molecular weight catalytic antioxidants, oxygen exposures in infants with hyaline membrane disease as well as BPD (39) . Recently, Sunday and colleagues reported therefore, is a potential therapy for the prevention of BPD in premature infants. that BLP promotes the development of BPD in fetal baboons (40). In this study, we observed that urine BLP levels are greatly
